GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » E10

Panacea Biotec (BOM:531349) E10 : ₹10.60 (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Panacea Biotec's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹0.740. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹10.60 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-04), Panacea Biotec's current stock price is ₹466.20. Panacea Biotec's E10 for the quarter that ended in Dec. 2024 was ₹10.60. Panacea Biotec's Shiller PE Ratio of today is 43.98.

During the past 13 years, the highest Shiller PE Ratio of Panacea Biotec was 42.23. The lowest was 23.50. And the median was 34.80.


Panacea Biotec E10 Historical Data

The historical data trend for Panacea Biotec's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec E10 Chart

Panacea Biotec Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Panacea Biotec Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 11.92 10.60

Competitive Comparison of Panacea Biotec's E10

For the Biotechnology subindustry, Panacea Biotec's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Biotec's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's Shiller PE Ratio falls into.


;
;

Panacea Biotec E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Panacea Biotec's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.74/158.3229*158.3229
=0.740

Current CPI (Dec. 2024) = 158.3229.

Panacea Biotec Quarterly Data

per share eps CPI Adj_EPS
200603 9.360 45.521 32.554
200703 21.850 48.581 71.207
200803 18.250 52.407 55.134
200903 -9.820 56.615 -27.462
201003 11.460 65.030 27.901
201103 22.980 70.768 51.411
201203 -32.840 76.889 -67.621
201303 -38.250 85.687 -70.674
201403 -18.310 91.425 -31.708
201503 -17.390 97.163 -28.336
201603 -2.970 102.518 -4.587
201703 -9.180 105.196 -13.816
201803 -12.410 109.786 -17.896
201806 -5.750 111.317 -8.178
201809 -15.830 115.142 -21.767
201812 -2.600 115.142 -3.575
201903 30.349 118.202 40.650
201906 -4.620 120.880 -6.051
201909 -12.250 123.175 -15.746
201912 -3.480 126.235 -4.365
202003 -11.370 124.705 -14.435
202006 -5.580 127.000 -6.956
202009 -3.160 130.118 -3.845
202012 -6.540 130.889 -7.911
202103 -8.840 131.771 -10.621
202106 -9.360 134.084 -11.052
202109 -8.650 135.847 -10.081
202112 -8.030 138.161 -9.202
202203 202.100 138.822 230.490
202206 -9.170 142.347 -10.199
202209 2.560 144.661 2.802
202212 3.160 145.763 3.432
202303 -2.030 146.865 -2.188
202306 1.790 150.280 1.886
202309 -1.350 151.492 -1.411
202312 -0.370 152.924 -0.383
202403 -0.230 153.035 -0.238
202406 -2.590 155.789 -2.632
202409 0.770 157.882 0.772
202412 0.740 158.323 0.740

Add all the adjusted EPS together and divide 10 will get our e10.


Panacea Biotec  (BOM:531349) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Panacea Biotec's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=466.20/10.60
=43.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Panacea Biotec was 42.23. The lowest was 23.50. And the median was 34.80.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Panacea Biotec E10 Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec Business Description

Traded in Other Exchanges
Address
Mathura Road, B-1 Extension/G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec Headlines

No Headlines